🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.

181 citations

Matthew I. Milowsky, Daniel P. Petrylak, Christopher Hoimes, Thomas W. Flaig, Nataliya Mar +20 more

N/A
0.641DataRank · unranked
71 citations

Nabil Adra, Pongwut Danchaivijitr, Maksym Sabadash, Alejo Rodriguez-Vida, Zhentao Zhang +21 more

4 citations

J. Robert Beck, Andres Correa, Chethan Ramamurthy, Daniel M. Geynisman, Elizabeth A. Handorf

5 citations

Yidong Chen, Jonathan Gelfond, Teresa L. Johnson‐Pais, Robin J. Leach, Chethan Ramamurthy +3 more

4 citations

Karen Wheeler, Shaun Trecarten, Zaineb Hassouneh, Niannian Ji, Yi‐Fen Lee +3 more